
Sign up to save your podcasts
Or


Topical therapies are a mainstay of psoriasis care but can be challenging to use. Hear what challenges they present and how the latest topicals - Tapinarof and Roflumilast could revolutionize topical treatments from dermatologist and NPF Medical Board member, Dr. Larry Green, Aesthetics and Dermatology Center in Rockville, MD. This Psound Bytes episode is provided with support from AbbVie, Amgen, Bristol Myers Squibb and Janssen.
By National Psoriasis Foundation4.8
3838 ratings
Topical therapies are a mainstay of psoriasis care but can be challenging to use. Hear what challenges they present and how the latest topicals - Tapinarof and Roflumilast could revolutionize topical treatments from dermatologist and NPF Medical Board member, Dr. Larry Green, Aesthetics and Dermatology Center in Rockville, MD. This Psound Bytes episode is provided with support from AbbVie, Amgen, Bristol Myers Squibb and Janssen.

21,956 Listeners

43,882 Listeners

31,987 Listeners

30,716 Listeners

43,605 Listeners

9,501 Listeners

112,049 Listeners

56,516 Listeners

3,755 Listeners

165,333 Listeners

4,740 Listeners

6,445 Listeners

29,170 Listeners

30 Listeners

19,738 Listeners